Cencora Financial Ratios
NYSE: CORHealth CareOther PharmaceuticalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Cencora ratio analysis
Cencora earned a net margin of 0.5% in FY 2025, down from 0.5% a year earlier. Gross margin was 3.6% compared with a median of 3.0% over the prior 9 years. Return on equity reached 103.1%, meaning Cencora generated 1.03 dollars of profit for every dollar of shareholders' equity, an unusually high figure that often reflects a small equity base after share buybacks.
Debt-to-equity stood at 5.08 versus 6.79 the year before, and the current ratio was 0.90. At the end of FY 2025, COR traded at 38.0 times earnings; across the 9 fiscal years shown, its year-end P/E ranged from 12.2 to 50.5, with a median of 20.3. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Cencora financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 38.04 | 29.21 | 21.10 | 16.83 | 16.21 | — | 20.26 | 12.25 | 50.46 | 12.78 |
| Price / sales | 0.18 | 0.15 | 0.14 | 0.12 | 0.12 | 0.10 | 0.10 | 0.12 | 0.12 | 0.12 |
| Price / book | 38.91 | 67.59 | 69.82 | — | 110.46 | — | 5.98 | 6.85 | 8.75 | 8.05 |
| Gross margin | 3.6% | 3.4% | 3.4% | 3.5% | 3.2% | 2.7% | 2.9% | 2.7% | 3.0% | 2.9% |
| Operating margin | 0.8% | 0.7% | 0.9% | 1.0% | 1.1% | -2.7% | 0.6% | 0.9% | 0.7% | 1.0% |
| Net margin | 0.5% | 0.5% | 0.7% | 0.7% | 0.7% | -1.8% | 0.5% | 1.0% | 0.2% | 1.0% |
| Free cash flow margin | 1.0% | 1.0% | 1.3% | 0.9% | 1.0% | 1.0% | 1.1% | 0.6% | 0.7% | 1.8% |
| Return on equity (ROE) | 103.1% | 233.6% | 334.3% | — | 689.5% | — | 29.7% | 56.5% | 17.7% | 67.1% |
| Return on assets (ROA) | 2.0% | 2.2% | 2.8% | 3.0% | 2.7% | -7.7% | 2.2% | 4.4% | 1.0% | 4.2% |
| Debt / equity | 5.08 | 6.79 | 9.17 | — | 29.93 | — | 1.45 | 1.47 | 1.67 | 1.97 |
| Current ratio | 0.90 | 0.88 | 0.88 | 0.91 | 0.94 | 0.98 | 0.95 | 0.93 | 0.91 | 0.90 |
| Revenue growth | 9.3% | 12.1% | 9.9% | 11.5% | 12.7% | 5.7% | 6.9% | 9.7% | 4.3% | 8.0% |
| EPS growth | 5.7% | -11.7% | 6.1% | 8.8% | — | -512.1% | -46.3% | 359.1% | -74.1% | — |